Streamex
STEXMarket price data through October 13, 2026.
Performance
Sep 2025 – Oct 2026
Track record
How this pick has done since Benson first called it.
- Benson Return
- -54%
- How much this stock is up since Benson first picked it — measured from the price at the time of that first pick, not from today.
- First pick price
- ~$1
- Roughly what one share cost when Benson first picked this stock. This is the starting line for the Benson Return.
- Tracking since
- April 2026
- The month this stock first became a Benson pick.
- Tracking duration
- 5 months
- How long Benson has been tracking this pick.
About Streamex
Streamex used to be BioSig Technologies, a heart-monitoring device maker, and is now rebuilding itself around tokenized gold. It turns physical gold into digital tokens that can be traded around the clock, like putting a vault of gold bars on your phone. The business is brand new, so this is an early stage bet.
The case for and against
Both sides of the story, in plain English.
- Cash, No Debt
The company ended June 2026 with about 41.8 million dollars in cash, gold, digital assets and investments, and no debt. Total equity was 147.1 million dollars. Management guides to roughly 1.1 million dollars of monthly cash burn, which gives it a long runway to build.
- First Gold Income
In the second quarter the gold token platform booked its first income, about 146 thousand dollars of gold lease income. It is small, but it shows the new product works and can earn a return. The company also holds 15.5 million dollars of physical gold behind the program.
- Big Losses
The company lost about 61 million dollars in the first six months of 2026. More than 32 million dollars of that was stock based pay and other non-cash items, but income from the new business is still tiny next to the loss. Profitability and momentum are weak.
- Unproven Pivot
This is a former medical device company with a brand new business, a market value near 100 million dollars, and a stock that swings about twice as much as the market. The old heart-monitoring patents may be sold or licensed, but no offer exists yet. Results can change fast either way.
Other companies we track
How to read this page
This automated research summary uses Financial Modeling Prep market data through 2026-10-13. Model signals, scores, and risk labels can change and may be incomplete or wrong.
Want Benson to watch STEX for you?
Get the app to follow every Benson pick live — and let Benson do the research for you.
Download on the App Store
Download Android app